The Pharmaceutical Care Management Association (PCMA) had an independent third party conduct a survey of its members to assess the potential impact on monthly premiums for Medicare Prescription Drug Plans (PDPs) if all drug manufacturer rebates and pharmacy direct and
The meeting was “mostly on issues where we had common ground,” like opioid prescribing. But he and others voiced their opposition to point-of-sale rebates
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on new National Health Expenditure (NHE) data by the Centers for Medicare & Medicaid Services (CMS) on prescription drug costs, showing that pharmacy benefit managers (PBMs) reduce
A recent article (“The Corporate Scam that Even Trump Opposes: PBMs”) attacks the one industry that is both reducing prescription drug costs and improving quality: pharmacy benefit managers (PBMs). The White House fiscal year 2019 budget included many cost-saving items PBMs have
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on health care proposals reportedly included in the Administration’s proposed 2019 budget: “While it’s unclear what impact last night’s White House 2019 budget preview will have given
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the decision to raise Gleostine’s price from $50 to $768: “The drug company’s decision to raise the price of the forty-year-old drug Gleostine by 1400% –
The Medicare Prescription Drug Rebate Rule PCMA Urges Congress to Permanently Repeal Rebate Rule This Year The Medicare Part D prescription drug benefit provides our nation’s seniors with affordable drug coverage, which is more important now than ever. The rebate
The evidence is clear: prescription drug rebates negotiated by pharmacy benefit companies with drug companies are not correlated with drug list prices, which are set solely by drug companies. A recent analysis using Centers for Medicare and Medicaid Services (CMS)
Pharmacy Benefit Companies Innovate to Provide Choice for Clients, Lower Costs for Patients Even as Congress considers more government intervention and “drug pricing” legislation that ironically may prove only to increase prescription drug costs, pharmacy benefit companies continue to evolve
©2024 PCMA. All Rights Reserved.
